微粒化纯化黄酮类组分对慢性静脉疾病患者静脉血流动力学的影响:基于数字光电容积描记法的评估
本回顾性分析纳入2018年2月至2020年7月土耳其布尔萨门诊诊断的721例C0-C4级慢性静脉疾病患者,评估每日口服MPFF 1000 mg并穿戴弹力袜6个月后数字光电容积描记法测得的静脉血流动力学变化。结果显示静脉再充盈时间和静脉泵功能、静脉临床严重程度评分及CIVIQ-20生活质量评分均较诊断时显著改善。
要点
- MPFF 1000 mg每日一次联合弹力袜治疗6个月与静脉再充盈时间、静脉泵功能显著改善相关。
- 静脉临床严重程度评分(VCSS)均值从诊断时7.9降至6个月时3.1(P<0.05)。
- CIVIQ-20评分在6个月随访时较诊断时显著改善(20.1 vs 38.6,P<0.01)。
核心结论
- 在C0-C4级慢性静脉疾病患者中,MPFF治疗联合穿戴弹力袜6个月与光电容积描记法测得的静脉血流动力学参数、临床严重程度及生活质量指标的统计学显著改善相关。
研究设计与样本
- 回顾性分析,纳入2018年2月至2020年7月土耳其布尔萨一家门诊诊所诊断的慢性静脉疾病患者。
- 符合建议治疗策略(MPFF 1000 mg片剂每日一次口服及弹力袜)并完成随访的患者纳入分析。
- 共纳入721例C0-C4级慢性静脉疾病患者,平均年龄52岁。
- 在诊断时和6个月随访时使用数字光电容积描记法测量静脉再充盈时间和静脉泵功能,同时获取静脉临床严重程度评分,患者完成20项慢性静脉功能不全问卷。
主要发现
- 光电容积描记法显示静脉再充盈时间从诊断时19.0秒增加至6个月时27.4秒(P<0.05)。
- 静脉泵功能从诊断时2.0%增加至6个月时4.9%(P<0.05)。
- 静脉临床严重程度评分均值从诊断时7.9改善至6个月时3.1(P<0.05)。
- CIVIQ-20评分均值在6个月随访时较诊断时显著改善(20.1 vs 38.6,P<0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Micronized purified flavonoid fraction (MPFF) is the most widely prescribed and well-studied venoactive drug available for the treatment of chronic venous disease (CVD). Photoplethysmography (PPG) is used to quantitatively measure venous hemodynamics and provide information about the overall function of the venous system. The aim of this study was to use digital PPG to evaluate the effects of MPFF on venous hemodynamics in patients with CVD. METHODS: Patients diagnosed with CVD at an outpatient clinic in Bursa, Turkey between February 2018 and July 2020 were assessed for inclusion in this retrospective analysis. Patients who complied with the advised treatment strategy (MPFF 1,000 mg tablets taken orally once daily and compression garments) and attended follow-up visits were included in the analysis. Digital PPG was used to measure venous refilling time (VRT) and venous pumping capacity (VPC) at diagnosis and 6 months of follow-up. The Venous Clinical Severity Score (VCSS) was also obtained at these visits, and patients completed the 20-item Chronic Venous Insufficiency Questionnaire (CIVIQ-20). RESULTS: In total, 721 patients (mean age 52 years) with C0-C4 CVD were included in the study. PPG showed that VRT and VPC increased significantly from 19.0 sec to 2.0%, respectively, at diagnosis to 27.4 and 4.9%, respectively, at 6 months (both P < 0.05). Mean VCSS improved significantly from 7.9 at diagnosis to 3.1 at 6 months (P < 0.05). Mean CIVIQ-20 score also improved significantly at the 6-month follow-up (20.1 vs 38.6 at diagnosis; P < 0.01). CONCLUSIONS: In patients with C0-C4 CVD, 6 months of MPFF treatment plus the wearing of compression garments was associated with statistically significant improvements in venous hemodynamic parameters measured by PPG, as well as measures of clinical severity and quality of life.
引用
- Guven H. Effect of Micronized Purified Flavonoid Fraction on Venous Hemodynamics Evaluated Using Digital Photoplethysmography in Patients with Chronic Venous Disease. Ann Vasc Surg. 2024. PMID: 39025225. doi:10.1016/j.avsg.2024.06.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。